Cargando…
A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis
BACKGROUND: To date, measurement of intracellular cystine is used for the therapeutic monitoring of patients affected by cystinosis in treatment with cysteamine. Since this method is time and sample consuming, development of a faster method to quantify cysteamine would be extremely useful in order t...
Autores principales: | Franzin, Martina, Rossetto, Silvia, Ruoso, Rachele, Del Savio, Rossella, Stocco, Gabriele, Decorti, Giuliana, Addobbati, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632017/ https://www.ncbi.nlm.nih.gov/pubmed/36329442 http://dx.doi.org/10.1186/s13023-022-02540-1 |
Ejemplares similares
-
Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy
por: Franzin, Martina, et al.
Publicado: (2023) -
A Validated HPLC–Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside
por: Franzin, Martina, et al.
Publicado: (2022) -
Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
por: Klank, Sabrina, et al.
Publicado: (2023) -
Cystinosis: Therapy adherence and metabolic monitoring in patients treated with immediate-release cysteamine
por: Linden, Simone, et al.
Publicado: (2020) -
Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
por: Bouazza, Naïm, et al.
Publicado: (2011)